Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 03/09/2019

Debbie Rigby rounds up the latest in research news Reduction in Use of Risperidone for Dementia in Australia Risperidone is the only antipsychotic approved in Australia for the management of the behavioural and psychological symptoms of dementia (BPSD). In June 2015, the TGA amended the indication to restrict use in BPSD to patients with Alzheimer’s

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Wholesaling deal needs ‘radical restructure’ in 8CPA

Lazy choice of photo/illustration

Russell Smith

Hi, I’m your pharmacist!

A variation I use is 'I will be as fast as I safely can'

Troy Winslade

Monopolists a threat to small business

I'm sorry, but this appears to be a poor article. The "socialist" bank of the day was the Commonwealth Bank...but…

Tod O'Connor

Wholesaling deal needs ‘radical restructure’ in 8CPA

If the CSO money is redistributed directly to rural pharmacies then a wholesaler would probably surcharge deliveries to these rural…

Ernie Hanson

Research Roundup

Previous GPs, practice staff value community pharmacy ‘safety net’

Next We're back

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous GPs, practice staff value community pharmacy ‘safety net’

Next We're back

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.